{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:18:01Z","timestamp":1787163481964,"version":"build-2736575974"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T00:00:00Z","timestamp":1530057600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Viamet Pharmaceuticals, Inc"},{"name":"TCG Lifesciences, Pvt. Ltd."},{"name":"OpAns"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10,1]]},"DOI":"10.1093\/jac\/dky242","type":"journal-article","created":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T15:11:24Z","timestamp":1527693084000},"page":"2815-2822","source":"Crossref","is-referenced-by-count":38,"title":["The novel fungal CYP51 inhibitor VT-1598 is efficacious alone and in combination with liposomal amphotericin B in a murine model of cryptococcal meningitis"],"prefix":"10.1093","volume":"73","author":[{"given":"E P","family":"Garvey","sequence":"first","affiliation":[{"name":"Viamet Pharmaceuticals, Inc., Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A D","family":"Sharp","sequence":"additional","affiliation":[{"name":"Evotec UK Ltd, Macclesfield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P A","family":"Warn","sequence":"additional","affiliation":[{"name":"Evotec UK Ltd, Macclesfield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C M","family":"Yates","sequence":"additional","affiliation":[{"name":"Viamet Pharmaceuticals, Inc., Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R J","family":"Schotzinger","sequence":"additional","affiliation":[{"name":"Viamet Pharmaceuticals, Inc., Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,6,26]]},"reference":[{"key":"key\n\t\t\t\t20180921035230_dky242-B1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/0003-4819-103-4-533","article-title":"Cryptococcosis in the acquired immunodeficiency syndrome","volume":"103","author":"Kovacs","year":"1985","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180921035230_dky242-B2","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/cid\/ciw125","article-title":"Incidence of opportunistic infections and the impact of antiretroviral therapy among HIV-infected adults in low- and middle-income countries: a systematic review and meta-analysis","volume":"62","author":"Low","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180921035230_dky242-B3","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180921035230_dky242-B4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1473-3099(13)70078-1","article-title":"Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries","volume":"13","author":"Loyse","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180921035230_dky242-B5","doi-asserted-by":"crossref","first-page":"e56269.","DOI":"10.1371\/journal.pone.0056269","article-title":"Epidemiology of cryptococcal meningitis in the US: 1997\u20132009","volume":"2","author":"Pyrgos","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180921035230_dky242-B6","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1110404","article-title":"Combination antifungal therapy for cryptococcal meningitis","volume":"368","author":"Day","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180921035230_dky242-B7","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jinf.2014.10.007","article-title":"Neurological, visual, and MRI brain scan findings in 87 South African patients with HIV-associated cryptococcal meningoencephalitis","volume":"70","author":"Loyse","year":"2015","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20180921035230_dky242-B8","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.cmi.2016.04.022","article-title":"Cryptococcosis \u2013 the impact of delay to diagnosis","volume":"22","author":"Aye","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180921035230_dky242-B9","first-page":"113","article-title":"Toxicity of amphotericin B deoxycholate-based induction therapy in patients with HIV-associated cryptococcal meningitis","volume":"50","author":"Bicanic","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180921035230_dky242-B10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1517\/17425255.2014.883379","article-title":"Clinically relevant drug\u2013drug interactions between antiretrovirals and antifungals","volume":"10","author":"Vadlapatla","year":"2014","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"key\n\t\t\t\t20180921035230_dky242-B11","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.1128\/AAC.01299-15","article-title":"Increased antifungal drug resistance in clinical isolates of Cryptococcus neoformans in Uganda","volume":"59","author":"Smith","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180921035230_dky242-B12","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw076","article-title":"Retrospective study of cryptococcal meningitis with elevated minimum inhibitory concentration to fluconazole in immunocompromised patients","volume":"3","author":"Nasri","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"key\n\t\t\t\t20180921035230_dky242-B13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180921035230_dky242-B14","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1016\/j.bmcl.2017.06.037","article-title":"Design and optimization of highly-selective, broad spectrum fungal CYP51 inhibitors","volume":"27","author":"Yates","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"key\n\t\t\t\t20180921035230_dky242-B15","article-title":"Crystal structure of the new investigational drug candidate VT-1598 in complex with Aspergillus fumigatus sterol 14\u03b1-demethylase provides insights into its broad-spectrum antifungal activity","volume":"561","author":"Hargrove","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180921035230_dky242-B16","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2165\/0003088-200847120-00003","article-title":"The enzymatic basis of drug-drug interactions with systemic triazole antifungals","volume":"47","author":"Nivoix","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"key\n\t\t\t\t20180921035230_dky242-B17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1081\/ERC-120015045","article-title":"Assessing pregnancy risks of azole antifungals using a high throughput aromatase inhibition assay","volume":"28","author":"Kragie","year":"2002","journal-title":"Endocr Res"},{"key":"key\n\t\t\t\t20180921035230_dky242-B18","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/bdra.20189","article-title":"Prenatal exposure to fluconazole: an identifiable dysmorphic phenotype","volume":"73","author":"Lopez-Rangel","year":"2005","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"key\n\t\t\t\t20180921035230_dky242-B19","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/jac\/dkx410","article-title":"Fungal-specific Cyp51 inhibitor VT-1598 demonstrates in vitro activity against Candida and Cryptococcus species, endemic fungi, including Coccidioides species, Aspergillus species and Rhizopus arrhizus","volume":"73","author":"Wiederhold","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180921035230_dky242-B20","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02258-17","article-title":"The novel fungal Cyp51 inhibitor VT-1598 is efficacious in experimental models of central nervous system coccidioidomycosis caused by Coccidioides posadasii and Coccidioides immitis","volume":"62","author":"Wiederhold","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180921035230_dky242-B21","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1128\/AAC.00216-13","article-title":"Pharmacokinetics and pharmacodynamics of fluconazole for cryptococcal meningoencephalitis: implications for antifungal therapy and in vitro susceptibility breakpoints","volume":"57","author":"Sudan","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180921035230_dky242-B22","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1128\/AAC.00048-11","article-title":"Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates obtained through population-based surveillance in South Africa in 2002-2003 and 2007-2008","volume":"55","author":"Govender","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180921035230_dky242-B23","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1517\/14656566.9.6.927","article-title":"Fungicidal versus fungistatic: what\u2019s in a word?","volume":"9","author":"Lewis II","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"key\n\t\t\t\t20180921035230_dky242-B24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/jac\/41.3.397","article-title":"Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B against Cryptococcus neoformans","volume":"41","author":"Klepser","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180921035230_dky242-B25","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1128\/AAC.28.5.648","article-title":"Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans","volume":"28","author":"Humphrey","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180921035230_dky242-B26","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1128\/AAC.06015-11","article-title":"Experimental central nervous system aspergillosis therapy: efficacy, drug levels and localization, immunohistopathology, and toxicity","volume":"56","author":"Clemons","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180921035230_dky242-B27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneurol.2016.167","article-title":"Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy","volume":"13","author":"Williamson","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"key\n\t\t\t\t20180921035230_dky242-B28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.7326\/0003-4819-113-3-183","article-title":"Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS: a randomized trial","volume":"113","author":"Larsen","year":"1990","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180921035230_dky242-B29","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/cid\/cit794","article-title":"Determinants of mortality in a combined cohort of 501 patients with HIV-associated cryptococcal meningitis: implications for improving outcomes","volume":"58","author":"Jarvis","year":"2014","journal-title":"Clin Inf Dis"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/10\/2815\/25770447\/dky242.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T17:28:46Z","timestamp":1571419726000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/73\/10\/2815\/5045560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,26]]},"references-count":29,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,6,26]]},"published-print":{"date-parts":[[2018,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dky242","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,10]]},"published":{"date-parts":[[2018,6,26]]}}}